Contact information
Research groups
Xinchun Gu
PhD
Researcher
I am an epidemiologist and pharmacist, with my research primarily focusing on the surveillance of infectious diseases in England and the evaluation of vaccine efficacy and safety. I currently use primary care data from the Oxford-Royal College of General Practitioners Research and Surveillance Centre (Oxford-RCGP RSC), which collects data from more than 1900 practices across England and Wales, to evaluate the trend of respiratory infectious disease in the UK. I am also experienced in using primary care data from Clinical Practice Research Datalink (CPRD) and its linked external databases.
Prior to joining the University of Oxford, I completed my PhD in pharmacoepidemiology at the University of Manchester. I earned a master's degree in clinical pharmacy from Peking University and a bachelor's degree in pharmaceutical science from Sun Yat-Sen University.
Recent publications
-
COVID-19 and influenza vaccine uptake among pregnant women in national cohorts of England and Wales
Journal article
Gu X. et al, (2024), npj Vaccines, 9
-
Sleeper frameworks for Pathogen X: surveillance, risk stratification, and the effectiveness and safety of therapeutic interventions
Journal article
de Lusignan S. et al, (2024), The Lancet Infectious Diseases, 24, e417 - e418
-
A Public Health Response to Pathogen X: Safeguarding Communities through Frameworks for Emerging Epidemics and Pandemics
Report
Shi T. et al, (2024)
-
Postpandemic Sentinel Surveillance of Respiratory Diseases in the Context of the World Health Organization Mosaic Framework: Protocol for a Development and Evaluation Study Involving the English Primary Care Network 2023-2024
Journal article
Gu X. et al, (2024), JMIR Public Health and Surveillance, 10
-
Postpandemic Sentinel Surveillance of Respiratory Diseases in the Context of the World Health Organization Mosaic Framework: Protocol for a Development and Evaluation Study Involving the English Primary Care Network 2023-2024 (Preprint)
Preprint
Gu X. et al, (2023)